Drug class
Topical antiandrogenic steroid; 17-alpha-estradiol
Mechanism of action
Has weak estrogenic activity and may inhibit 5-alpha-reductase and local androgen-dependent effects in hair follicles; the clinical mechanism in androgenetic alopecia is not fully established.
General use cases
- Topical treatment of androgenetic alopecia in men and women in countries where alfatradiol products are authorised; benefit is formulation- and jurisdiction-specific
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
